EXHIBIT 11.1
SONUS PHARMACEUTICALS, INC.
COMPUTATION OF NET INCOME (LOSS) PER SHARE
Three Months Ended Six Months Ended
June 30, June 30,
----------------------------------- -------------------------------------
1996 1995 1996 1995
-------------- --------------- --------------- ----------------
Net income (loss) . . . . . . . . . . . . . . . $ 980,922 $ (1,624,111) $ (3,726,782) $ (890,983)
Weighted average shares outstanding . . . . . . 8,461,220 2,050,032 8,455,550 3,330,201
============== =============== =============== ================
Net effect of common stock equivalents
calculated using the treasury stock
method at the average quarterly price
of $18.64 per share, and treated as
outstanding for all periods presented . . . . 629,725 - - -
-------------- --------------- --------------- ----------------
Shares used in computation of net income
(loss) per share. . . . . . . . . . . . . . . 9,090,945 2,050,032 8,455,550 3,330,201
============== =============== =============== ================
Net income (loss) per share . . . . . . . . . . $ 0.11 $ (0.79) $ (0.44) $ (0.27)
============== =============== =============== ================